Yashovardhan Birla

It is the level and curvature of the yield curve that contains info on market expectations on economic prospects and inflation, says paper authored by Deputy Governor M D Patra and others

The Securities Appellate Tribunal (SAT) has quashed a Sebi order that had barred Yashovardhan Birla and others from the securities market for two years for alleged mis-utilisation of the IPO proceeds. The Sebi, in October 2020, restrained Birla Pacific Medspa Ltd, Yashovardhan Birla and eight others from the securities market for two years for mis-utilisation of the IPO proceeds. Birla Pacific Medspa Ltd (BPML), which came out with offer documents in March 2011, had floated its over Rs 65-core initial public offering (IPO) in June 2011. The regulator, in its order, said that the company made misstatements in the prospectus in respect of the objects of the IPO. Pursuant to Sebi's order, Yashovardhan Birla and other individuals moved SAT. These individuals were the signatories to the prospectus of Birla Pacific Medspa. In its order dated August 26, the SAT said that appellants did not make any misstatement in the prospectus. It, further, said that the finding given by the Sebi that

Birla Pacific Medspa Ltd (BPML), which came out with offer documents in March 2011, had floated its over Rs 65-core initial public offering (IPO) in June 2011

Kolkata-based UCO had given Birla Surya a credit limit of ₹100 crore.